How much funding has CRIAM raised?

CRIAM has raised $1.3M in total funding, most recently a Seed round.

Who are CRIAM's investors?

CRIAM's investors include SOSV, HAX Growth, Artesian Investments.

Where is CRIAM headquartered?

CRIAM is headquartered in Lisbon, Portugal.

CRIAM

Portable blood typing and diagnostics for emergency and remote care

Lisbon, Portugal · Founded 2016 · $1.3M raised

Headquarters: Lisbon
Employees: 1–10
Founded: 2016
Business Model: B2B

Website: criamknowledge.com
Total Funding: $1.3M
Last Round: $1.3M SeedNov 2021
Rounds: 1

About

CRIAM is a portable in vitro diagnostic company providing rapid point-of-care analysis for blood typing, sub-typing, disease detection, and nutrient measurement. The device operates without internet or power, making it suitable for use in emergency vehicles, remote locations, and resource-limited settings. CRIAM has conducted clinical trials with HCA in the US and multiple hospitals in Portugal and the UK, and is developing additional applications for infectious disease detection including COVID-19 and malaria.

Summary

CRIAM is a company based in Lisbon, Portugal, founded in 2016. It has raised $1.3M in total across 1 round, most recently a $1.3M Seed round in Nov 2021. Investors include SOSV, HAX Growth and Artesian Investments.